Kadant's stock performance was analyzed in comparison to CRi's performance.
2 reports, 1 independent
Updated Jul 10
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Kadant's stock performance was analyzed in comparison to CRi's performance.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Morgan Stanley analyst firm inquired about sequential demand trends and competitive dynamics with Kadant's CEO and management.Sub-event
Kadant's stock was analyzed against CRi's performance on August 19, 2025.1 source
Keep exploring
The entities involved
Related events
Coverage
Newest first; wire copies grouped- StockStory3 Reasons to Avoid CRI and 1 Stock to Buy Instead Carter’s stock price has taken a beating over the past six months, shedding 50.3% of its value and falling to $25.80 per share. This was partly drive